Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...

Microbot Medical (MBOT) presented for the first time the data from its ACCESS-PVI pivotal trial at the Society of Interventional Radiology annual meeting. The study was performed at three leading ...

Microbot Medical today announced pivotal trial data supporting the use of its Liberty endovascular surgical robot.

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is providing this reminder that data from the Company’s ACCESS-PVI trial will be ...